StockData
Alnylam Pharmaceuticals, Inc. logo

Alnylam Pharmaceuticals, Inc. (ALNY) stock

ALNYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/3049% below fair value
$149.40−7.10 (-4.54%)

Close on Nov 18, 2026Market cap $20.01BP/E 7.8Yield –

Alnylam Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Alnylam Pharmaceuticals's price to sales ratio was 4.4× on Nov 11, 2026, against 18.5× a year earlier. Over the last 5 years it ranged from 4.4× to 30.4×, with a median of 16.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20264.4×−11.9
2025Dec 31, 202516.3×+1.9
2024Dec 31, 202414.5×+0.5
2023Dec 29, 202313.9×−16.5
2022Dec 30, 202230.4×+3.4
2021Dec 31, 202127.0×−10.6
2020Dec 31, 202037.6×−38.2
2019Dec 31, 201975.8×−4.4
2018Dec 31, 201880.2×+76.1
2011Jul 29, 20114.1×+0.2
2010Dec 31, 20103.9×–

More Alnylam Pharmaceuticals figures

See a number that looks wrong?